Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers
J. E. Wiedmeier-Nutor et al · Nature Publishing Group · 2026
Resource access
Open the content from the main option or choose another available source.
Open access available
How to cite
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, J. E. W. N. E. (2026). Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers. https://doi.org/10.1038/s41408-026-01508-9
MLA
al, J. E. Wiedmeier-Nutor et. "Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers." 2026. https://doi.org/10.1038/s41408-026-01508-9.
Chicago
al, J. E. Wiedmeier-Nutor et. 2026. "Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers.". https://doi.org/10.1038/s41408-026-01508-9.
Harvard
al, J. E. W. N. E. 2026, Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers, Nature Publishing Group, available at: https://doi.org/10.1038/s41408-026-01508-9 [Accessed 9 Aug. 2026].
Resource details
Bibliographic information to help confirm that this is the correct material.
- Title
- Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers
- Author / contributors
- J. E. Wiedmeier-Nutor et al
- Publisher
- Nature Publishing Group
- Publication year
- 2026
- ISSN
- 2044-5385
- ISSN
- 2044-5385
- Language
- English